Ambu A/S

Common Name
Ambu
Country
Denmark
Sector
Healthcare
Industry
Medical Devices
Employees
5,000
Ticker
AMBU B
Exchange
NASDAQ COPENHAGEN A/S
Description
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and d...

Financial Statements of Ambu

Below are the financial statements of Ambu, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of DKK20242023
Revenue
5,391a
4,775a
Production costs
-2,190a
-2,062a
Gross profit
3,201a
2,713a
Selling and distribution costs
-1,571a
-1,522a
Development costs
-325a
-295a
Management and administrative costs
-660a
-594a
Operating profit (EBIT) before special items
645a
302a
Special items
-334a
-8a
Operating profit (EBIT)
311a
294a
Financial income
16a
2a
Financial expenses
-27a
-86a
Profit before tax
300a
210a
Tax on profit for the year
-65a
-42a
Net profit for the year
235a
168a

Verified Sources Behind Ambu’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ambu’s data sources below and access millions more through our Disclosure Search.

a. Ambu's Annual Report 2024
Trace every data point back to Ambu’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?